Cardiovascular implications of obstructive sleep apnea associated with the presence of a patent foramen ovale

Sleep Medicine Reviews

Volumn 18, Issue 5, 2014, Pages 399-404

  Kar, Subrata ^a  

^a University of Missouri   (United States)

Author keywords

Cardiovascular disease; Obstructive sleep apnea; Patent foramen ovale; Percutaneous closure; Stroke

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL STUDY; HEART SURGERY; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; OBSERVATIONAL STUDY; PATENT FORAMEN OVALE; PERCUTANEOUS PATENT FORAMEN OVALE CLOSURE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SLEEP DISORDERED BREATHING; ADULT; CARDIOVASCULAR DISEASES; COMPLICATION; FEMALE; MALE; RISK FACTOR; STROKE;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; FORAMEN OVALE, PATENT; HUMANS; MALE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; STROKE;

EID: 84926011299     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2014.02.002     Document Type: Review

References (35)

1. Johansson M.C., Eriksson P., Dellborg M. The significance of patent foramen ovale: a current review of associated conditions and treatment. Int J Cardiol 2009, 134:17-24.
2. Kutty S., Sengupta P.P., Khandheria B.K. Patent foramen ovale: the known and the to be known. JAm Coll Cardiol 2012, 59:1665-1671.
3. Lau E.M., Yee B.J., Grunstein R.R., Celermajer D.S. Patent foramen ovale and obstructive sleep apnea: a new association?. Sleep Med Rev 2010, 14:391-395.
4. Sommer R.J. Patent foramen ovale: where are we in 2009?. Am J Ther 2009, 16:562-572.
5. Johansson M.C., Eriksson P., Peker Y., Hedner J., Rastam L., Lindblad U. The influence of patent foramen ovale on oxygen desaturation in obstructive sleep apnoea. Eur Respir J 2007, 29:149-155.
6. Calvert P.A., Rana B.S., Kydd A.C., Shapiro L.M. Patent foramen ovale: anatomy, outcomes, and closure. Nat Rev Cardiol 2011, 8:148-160.
7. Pellaton C., Heinzer R., Michel P., Eeckhout E. Patent foramen ovale and obstructive sleep apnoea: from pathophysiology to diagnosis of a potentially dangerous association. Arch Cardiovasc Dis 2011, 104:242-251.
8. Agarwal S., Bajaj N.S., Kumbhani D.J., Tuzcu E.M., Kapadia S.R. Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism. JACC Cardiovasc Interv 2012, 5:777-789.
9. Khairy P., O'Donnell C.P., Landzberg M.J. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 2003, 139:753-760.
10. Kitsios G.D., Dahabreh I.J., Abu Dabrh A.M., Thaler D.E., Kent D.M. Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence. Stroke 2012, 43:422-431.
11. Furlan A.J., Reisman M., Massaro J., Mauri L., Adams H., Albers G.W., et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. NEngl J Med 2012, 366:991-999.
12. Furlan A.J., Reisman M., Massaro J., Mauri L., Adams H., Albers G.W., et al. Study design of the CLOSURE I trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale. Stroke 2010, 41:2872-2883.
13. Carroll J.D., Saver J.L., Thaler D.E., Smalling R.W., Berry S., MacDonald L.A., et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. NEngl J Med 2013, 368:1092-1100.
14. Meier B., Kalesan B., Mattle H.P., Khattab A.A., Hildick-Smith D., Dudek D., et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. NEngl J Med 2013, 368:1083-1091.
15. Rosario I.C. Obstructive sleep apnea: a review and update. Minn Med 2011, 94:44-48.
16. Wolk R., Kara T., Somers V.K. Sleep-disordered breathing and cardiovascular disease. Circulation 2003, 108:9-12.
17. Lattimore J.D., Celermajer D.S., Wilcox I. Obstructive sleep apnea and cardiovascular disease. JAm Coll Cardiol 2003, 41:1429-1437.
18. Lurie A. Cardiovascular disorders associated with obstructive sleep apnea. Adv Cardiol 2011, 46:197-266.
19. Das A.M., Khan M. Obstructive sleep apnea and stroke. Expert Rev Cardiovasc Ther 2012, 10:525-535.
20. McNicholas W.T., Bonsigore M.R. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007, 29:156-178.
21. Somers V.K., White D.P., Amin R., Abraham W.T., Costa F., Culebras A., et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008, 118:1080-1111.
22. Fichter J., Bauer D., Arampatzis S., Fries R., Heisel A., Sybrecht G.W. Sleep-related breathing disorders are associated with ventricular arrhythmias in patients with an implantable cardioverter-defibrillator. Chest 2002, 122:558-561.
23. Shepard J.W., Garrison M.W., Grither D.A., Dolan G.F. Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea. Chest 1985, 88:335-340.
24. Loke Y.K., Brown J.W., Kwok C.S., Niruban A., Myint P.K. Association of obstructive sleep apnea with risk of serious cardiovascular events: systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 2012 Sep 1, 5(5):720-728. Epub 2012 Jul 24.
25. Peker Y., Hedner J., Norum J., Kraiczi H., Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002, 166:159-165.
26. Gottlieb D.J., Yenokyan G., Newman A.B., O'Connor G.T., Punjabi N.M., Quan S.F., et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 2010, 122:352-360.
27. Shanoudy H., Soliman A., Raggi P., Liu J.W., Russell D.C., Jarmukli N.F. Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest 1998, 113:91-96.
28. Lau E.M., Jaijee S.K., Melehan K.L., Wong K.K., Yee B.J., Grunstein R.R., et al. Prevalence of patent foramen ovale and its impact on oxygen desaturation in obstructive sleep apnea. Int J Cardiol 2013, 165:35-40.
29. Pinet C., Orehek J. CPAP suppression of awake right-to-left shunting through patent foramen ovale in a patient with obstructive sleep apnoea. Thorax 2005, 60:880-881.
30. Ozdemir O., Beletsky V., Hachinski V., Spence J.D. Cerebrovascular events on awakening, patent foramen ovale and obstructive sleep apnea syndrome. JNeurol Sci 2008, 268:193-194.
31. Guchlerner M., Kardos P., Liss-Koch E., Franke J., Wunderlich N., Bertog S., et al. PFO and right-to-left shunting in patients with obstructive sleep apnea. JClin Sleep Med 2012, 8:375-380.
32. Silver B., Greenbaum A., McCarthy S. Improvement in sleep apnea associated with closure of a patent foramen ovale. JClin Sleep Med 2007, 3:295-296.
33. Agnoletti G., Iserin L., Lafont A., Sidi D., Desnos M. Obstructive sleep apnoea and patent foramen ovale: successful treatment of symptoms by percutaneous foramen ovale closure. JInterv Cardiol 2005, 18:393-395.
34. Beelke M., Angeli S., Del Sette M., Gandolfo C., Cabano M.E., Canovaro P., et al. Prevalence of patent foramen ovale in subjects with obstructive sleep apnea: a transcranial Doppler ultrasound study. Sleep Med 2003, 4:219-223.
35. Shaikh Z.F., Jaye J., Ward N., Malhotra A., de Villa M., Polkey M.I., et al. Patent foramen ovale in severe obstructive sleep apnea: clinical features and effects of closure. Chest 2013 Jan, 143(1):56-63.